Latest KFF Health News Stories
El gobierno dará medicamentos para prevenir el VIH gratis. ¿Calificas?
La administración Trump lanza plan para ofrecer gratis medicamentos preventivos contra el VIH a las personas que no tienen seguro de salud.
HHS Hands Out Free HIV Prevention Drugs. Do You Qualify?
Called “Ready, Set, PrEP,” the federal program will provide medication that can reduce the chances of getting AIDS to at-risk patients who don’t have insurance.
KHN’s ‘What The Health?’: How’s That Open Enrollment Going?
Open enrollment for the Affordable Care Act’s marketplace plans is halfway over and, so far, the number of people signing up is down, but not dramatically. Meanwhile, Congress and President Donald Trump can’t seem to agree on what to do about teen vaping, drug prices or “surprise” medical bills. And Democrats lurch to the left on abortion. Paige Winfield Cunningham of The Washington Post, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more health news.
This Story Contains A Warning That Might Cause Alarm — Or Apathy
Proposition 65 requires California businesses to label products and buildings with warnings about substances the state deems as toxic, ranging from aloe vera to asbestos. A state panel plans to debate whether to add acetaminophen, the active ingredient of common over-the-counter medications such as Tylenol, to the toxics list, raising questions about the value of these ubiquitous warnings.
New California Law May Expand Use Of HIV Prevention Drugs, With Caveats
Legislation that takes effect next July will let people buy the medications without a prescription for a limited period. Medical professionals say it’s a step in the right direction but will not significantly increase the use of the medicine without additional efforts.
La Casa Blanca revela norma final sobre transparencia de precios en salud
La norma establece que, a partir de 2021, los hospitales deben publicar los precios de todos sus servicios en internet, para que los consumidores tengan información.
White House Unveils Finalized Health Care Price Transparency Rule
The final directive drew swift responses from the hospital and insurance industries. The Trump administration also released a proposed rule that would require health insurers to spell out for all services beforehand just how much patients may owe for their out-of-pocket costs.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
KHN’s ‘What The Health’: Spending Bill Slowdown
It’s November, do you know where your HHS spending bill is? Still stuck in Congress. Meanwhile, lawmakers move ahead on restricting tobacco products for youth while the administration’s proposal is MIA. Rebecca Adams of CQ Roll Call and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more health news from the week. Also, Rovner interviews Dan Weissmann, host of the podcast “An Arm and a Leg.”
Voters Say Congress Needs To Curb Drug Prices, But Are Lawmakers Listening?
Nearly 8 in 10 Americans say the cost of prescription drugs is unreasonable, but the odds look grim for Congress to pass significant pricing legislation this year.
How Germany Averted An Opioid Crisis
Doctors are less likely to prescribe opioids in Germany and quicker to notice if a patient is at risk of abuse. And, for those who do experience addiction, treatment is easier to come by.
Listen: HHS Files Challenge Over Rights To Gilead’s HIV-Prevention Drug
KHN’s Shefali Luthra discusses the recent Trump administration lawsuit regarding the HIV-prevention drug Truvada.
FDA Keeps Brand-Name Drugs On A Fast Path To Market ― Despite Manufacturing Concerns
The agency approved Gilead’s “game changer” hepatitis C cure, bypassing concerns raised by its own federal inspectors.
Hospitals Take Shot At Opioid Makers Over Cost Of Treating Uninsured For Addiction
A few hundred hospitals have banded together to sue drugmakers in state courts, but far more are staying on the sidelines to avoid ‘unflattering attention’ about their role in the opioid crisis.
Moved Overseas For School, Stayed For Insulin
Katie West, an American health researcher who has lived in Germany the past three years, hasn’t mastered the language and misses her family. But not having to worry about the cost of her lifesaving medication makes it OK.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Pharma Sells States On ‘Netflix Model’ To Wipe Out Hep C. But At What Price?
Manufacturers of lucrative drugs say they’re offering discounts off the high sticker prices ― but taxpayers footing the big bills might never know what the state is paying or if it’s getting a good deal.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
KHN’s ‘What The Health?’: Democrats Do Drugs (Prices)
House Democrats start legislative work on House Speaker Nancy Pelosi’s prescription drug pricing bill; health is again a featured player in the Democratic presidential candidate debate; and courts around the country hold up President Donald Trump’s health agenda. This week, Margot Sanger-Katz of The New York Times, Tami Luhby of CNN, and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.
Health Care Stayed Front And Center At Democratic Debate
The topic, which polls show is top of mind among voters, kept returning throughout the fourth debate of Democratic presidential candidates.
